HRT FINANCIAL LP purchased $13K of SHPH
HRT FINANCIAL LP purchased 3,959 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at $3.30 on 2026-07-01.
How this was made
The 30-second read
Why it matters
A large owner (10% role) bought shares in the open market; however, the filing does not include any new company-specific fundamentals (no earnings, guidance, trial, or deal).
Market read
Traders may note mild sentiment support from accumulation, but the disclosed size and lack of fundamental updates make it low-conviction for positioning.
What to watch
The article does not disclose the owner’s broader trading history, intent, or whether other insiders/holders are simultaneously buying or selling.
Background
This is an SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Ticker impact
HRT Financial LP, a 10% owner, filed a Form 4 showing an open-market purchase of 3,959 SHPH shares at $3.30 on 2026-07-01.
Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.
Form 4 confirms the transaction details (shares, price, date) but provides no guidance, operational update, or material corporate event. The disclosed value (~$13.1k) is modest versus typical market-moving thresholds.
Market effects
No sector read-through; this is a single-company ownership transaction with no disclosed business change.
None indicated.
None indicated.
Counterpoint
The purchase may be routine (e.g., liquidity management or plan-related behavior) and the absence of a 10b5-1 plan does not necessarily imply a strong directional view.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4; shares purchased by a 10% owner.
- 10% ownerHRT Financial LP
Reported open-market purchase of 3,959 SHPH shares at $3.30 on 2026-07-01.